Exposure to two dolutegravir formulations in children in the ODYSSEY trial

International Workshop on HIV Pediatrics 2021

Abacavir Weight-Band Dosing for Infants in the First 4 Weeks of Life

International Workshop on HIV Pediatrics 2021

Assessing parental choice of Lopinavir/ritonavir granules intake to improve child adherence at Baylor-Mwanza, Tanzania.

International Workshop on HIV Pediatrics 2021

Caregivers perception on paedriatic Lopinavir/ritonavir formulations for HIV infected children at Baylor clinic, Mwanza-Tanzania.

International Workshop on HIV Pediatrics 2021

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (E/C/F/TAF) on Bone Safety Parameters in Children and Adolescents Living with HIV

International Workshop on HIV Pediatrics 2021

Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents in the ODYSSEY trial

International Workshop on HIV Pediatrics 2021

Neuropsychiatric manifestations and sleep disturbances in children and adolescents randomised to dolutegravir-based ART vs standard-of-care in the ODYSSEY trial

International Workshop on HIV Pediatrics 2021

Mutations associated with ineffectiveness of HIV-1 protease inhibitors in children in Abidjan, Côte d'Ivoire

International Workshop on HIV Pediatrics 2021

Early Trends in HIV Drug Resistance Mutations Among Pediatric and Young Adult (0-24 years) Clients in Sub-Saharan Africa

International Workshop on HIV Pediatrics 2021

HIV Drug Resistance Patterns Among Highly Treatment-Experienced Children, Adolescents and Young Adults in Sub-Saharan Africa

International Workshop on HIV Pediatrics 2021

The road to success is paved with dolutegravir: Dolutegravir treatment success among in children and adolescents living with HIV (CALHIV) at the Baylor Tanzania Centres of Excellence.

International Workshop on HIV Pediatrics 2021

Successful Scale- Up of Optimal Antiretroviral Regimens and Improvement in Viral Suppression for Children and Adolescents Living with HIV Amidst COVID 19 Pandemic In Kenya

International Workshop on HIV Pediatrics 2021

Challenges in the effective treatment of infant HIV undermine the potential impact of birth testing and neonatal ART: preliminary results from the LIFE trial in Mozambique and Tanzania

International Workshop on HIV Pediatrics 2021

Adolescent and caregiver perspectives on an enhanced adherence counseling intervention for youth with suspected HIV treatment failure in Kenya

International Workshop on HIV Pediatrics 2021

Adherence to Antiretroviral Therapy among Children Living with HIV in North-Central Nigeria: a Qualitative Evaluation of Barriers and Facilitators among Caregivers

International Workshop on HIV Pediatrics 2021

Viral Load Coverage and Suppression Around COVID-19: Eswatini

International Workshop on HIV Pediatrics 2021

The Baylor International Pediatric AIDS Initiative (BIPAI) Network’s progress towards the second and third UNAIDS 95-95-95 goals among CALHIV receiving care in pediatric HIV centers in six countries in sub-Saharan Africa.

International Workshop on HIV Pediatrics 2021

What are the drivers of improved viral suppression among HIV infected children (0-14 years)? Results from the national data warehouse in Kenya 2020

International Workshop on HIV Pediatrics 2021

Low Viral Suppression among Children < 3 Years Old On Two Protease Inhibitor Formulations In Kenya, 2015-2019

International Workshop on HIV Pediatrics 2021

Intensified technical assistance on multi-month dispensing of antiretroviral therapy to children and adolescents living with HIV resulted in achievement of the 85% PEPFAR benchmark in Nigeria

International Workshop on HIV Pediatrics 2021

“I now always go out to play”: Evaluating the impact of the New Horizons Initiative for third-line HIV treatment for pediatric patients in Kenya, Uganda and Zambia.

International Workshop on HIV Pediatrics 2021

MMD in children: Game-changer at no cost

International Workshop on HIV Pediatrics 2021

Optimizing index testing of biological children of parents and siblings of children in care: Lesson learned from the ELMA project in Cote d’Ivoire

International Workshop on HIV Pediatrics 2021

Reaching undiagnosed children living with HIV through index testing in Homa Bay, Kenya

International Workshop on HIV Pediatrics 2021